ITW vs STRO
Illinois Tool Works Inc (ITW) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Illinois Tool Works Inc (ITW) is a specialty industrial machinery company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ITW revenue for 2025-12-31 was $16.04B. Net income was $3.07B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ITW currently screens at market cap $72.53B and trailing P/E 21.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ITW and STRO stock pages for the full models.
Not investment advice.